发明申请
US20100197562A1 FUNCTIONALLY SELECTIVE ALPHA2C ADRENORECEPTOR AGONISTS
失效
功能选择性ALPHA2C ADRENORECEPTOR AGONISTS
- 专利标题: FUNCTIONALLY SELECTIVE ALPHA2C ADRENORECEPTOR AGONISTS
- 专利标题(中): 功能选择性ALPHA2C ADRENORECEPTOR AGONISTS
-
申请号: US12525641申请日: 2008-02-11
-
公开(公告)号: US20100197562A1公开(公告)日: 2010-08-05
- 发明人: Manuel De lera Ruiz , Kevin D. McCormick , Christopher W. Boyce , Robert G. Aslanian , Younong Yu , Pietro Mangiaracina , Junying Zheng , Michael Y. Berlin , Stephanie L. Ciesla , Chia-yu Huang , Bo Liang
- 申请人: Manuel De lera Ruiz , Kevin D. McCormick , Christopher W. Boyce , Robert G. Aslanian , Younong Yu , Pietro Mangiaracina , Junying Zheng , Michael Y. Berlin , Stephanie L. Ciesla , Chia-yu Huang , Bo Liang
- 申请人地址: US NJ Kenilworth US NJ Cranbury
- 专利权人: SCHERING CORPORATION AND PHARMACOPEIA, LLC,PHARMACOPEIA, INC.
- 当前专利权人: SCHERING CORPORATION AND PHARMACOPEIA, LLC,PHARMACOPEIA, INC.
- 当前专利权人地址: US NJ Kenilworth US NJ Cranbury
- 国际申请: PCT/US2008/001765 WO 20080211
- 主分类号: A61K31/506
- IPC分类号: A61K31/506 ; C07D403/14 ; A61K31/4178 ; C07D401/10 ; C07D487/04 ; A61K31/519 ; C07D401/14 ; A61K31/4439 ; A61K31/56 ; A61K38/02 ; A61P11/00 ; A61P29/00 ; A61P1/12 ; A61P9/00 ; A61P25/00 ; A61P25/24 ; A61P25/22 ; A61P25/18 ; A61P3/10 ; A61P19/02
摘要:
In its many embodiments, the present invention provides a novel class of biaryl compounds as inhibitors of ÿ2C adrenergic receptor agonists, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more conditions associated with the ÿ2C adrenergic receptors using such compounds or pharmaceutical compositions.
公开/授权文献
- US08501747B2 Functionally selective alpha2C adrenoreceptor agonists 公开/授权日:2013-08-06